drugset / Trial / NCT05240560
Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Multicenter, randomized, double blind, parallel-group, placebo-controlled proof of concept study evaluating efficacy and safety of BP1.3656 in patients with fatigue following ischemic stroke.
Timeline
- Start
- 2023-01-20
- Primary completion
- 2024-02-08
- Completion
- 2024-02-08
Outcome
Outcome not reported
Stopped (Enrollment): “Lack of recruitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BP1.3656 | Unknown | 30 ug | Oral |
| Subject | BP1.3656 | Unknown | 60 ug | Oral |
| Subject | BP1.3656 | Unknown | 90 ug | Oral |
Indications
No indication recorded.